CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹17,448 Cr | ₹13,454 Cr | ₹12,689 Cr | ₹11,732 Cr | ₹11,925 Cr |
What is the latest Total Non-Current Assets ratio of CIPLA ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹17,448 Cr |
| Mar2025 | ₹13,454 Cr |
| Mar2024 | ₹12,689 Cr |
| Mar2023 | ₹11,732 Cr |
| Mar2022 | ₹11,925 Cr |
How is Total Non-Current Assets of CIPLA Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹17,448 Cr | 29.69 | |
| Mar2025 | ₹13,454 Cr | 6.03 | |
| Mar2024 | ₹12,689 Cr | 8.16 | |
| Mar2023 | ₹11,732 Cr | -1.62 | |
| Mar2022 | ₹11,925 Cr | - | |
Compare Total Non-Current Assets of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹116,157.6 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| MANKIND PHARMA | ₹105,174.0 Cr | 0.6% | 7% | 4.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -0.3% |
4.1% |
-3.3% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses